Psoriasis trials in France

In France 37 Also abroad 274

37 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Brest, Reims, Toulon Cedex 9, Toulouse
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
Phase 2Taking people
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Where
Bordeaux, Caluire-et-Cuire, Chambray-lès-Tours, Nice, Orléans
Age
18 years and over
People
300 worldwide
Run by
AbbVie
See details and how to joinNCT06865105
No phaseTaking people
Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis
Where
Paris
Age
18 years to 75 years
People
144
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07460739
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Lille Cedex
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
No phaseTaking people
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
Where
Lille
Age
18 years and over
People
200
Run by
Janssen-Cilag Ltd.
See details and how to joinNCT07532226
Phase 3Taking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Nantes, Nice, Saint-Pierre
Age
40 years and over
People
3,040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
Phase 3Taking people
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Calais, Dijon, Nice
Age
4 years to 18 years
People
153 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00
No phaseTaking people
Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis
Where
Nice
Age
18 years to 80 years
People
100
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT05399433
Phase 2Taking people
Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
Where
Lyon, Marseille, Martigues, Nice, Saint-Etienne, Toulon, Villeurbanne
Age
18 years to 45 years
People
40
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT06742333
No phaseTaking people
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Where
Beauvais, Boulogne-Billancourt, Dijon, Le Mans, Niort, Romans-sur-Isère, Toulon
Age
18 years and over
People
700 worldwide
Run by
AbbVie
See details and how to joinNCT07039110
Phase 3Not yet taking people in France
Evaluation of the Efficacy and Safety of Bimekizumab (BZK) or Adalimumab (ADA) in the Treatment of Anterior Chest Wall Pain Associated With Active Axial Spondyloarthritis Refractory to NSAIDs With Hypothesis of Superiority of Bimekizumab
Where
Besancon Cedex, Boulogne-Billancourt, Caen Cedex 9, Chambray Les Tours, Clermont Ferrand Cedex 1, Corbeil-Essonnes, Creteil Cedex, Le Coudray, Le Mans Cedex 9, Lille Cedex, Limoges, Lomme Cedex, Marseille, Montivilliers, Montpellier Cedex 5, Nantes, Nimes Cedex 9, Orleans Cedex 2, Paris, Paris Cedex 10, Poitiers, Pontoise, Reims, Rouen Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy Cedex
Age
18 years to 60 years
People
150
Run by
University Hospital, Rouen
See details and how to joinNCT07836283 · EU 2025-520632-42-00
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Chambray Les Tours, Reims Cedex, Saint-Priest-en-Jarez, Toulouse
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 3Taking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Bordeaux, Le Kremlin Bicetre Cedex
Age
5 years to 17 years
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
No phaseTaking people
Cytokine Expression in Psoriasis Patients With and Without Joint Involvement
Where
Poitiers
Age
18 years to 100 years
People
40
Run by
Poitiers University Hospital
See details and how to joinNCT05307809
Phase 2Taking people
Early intervention in plaque psoriasis: is bimekizumab able to delay chronic inflammation? Prospective multicenter interventional study
Where
Grenoble Cedex 9, Lyon Cedex 03, Marseille, Martigues, Nice, St Etienne Cedex 2, Toulon, Villeurbanne Cedex
Age
18 years to 64 years
People
40
Run by
Centre Hospitalier Universitaire De Nice
See details and how to join2024-514647-29-01 · EU 2024-514647-29-01
No phaseTaking people
HLA B Leader in Patients With Psoriatic Arthritis
Where
Amiens
Age
18 years and over
People
658
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07718815
Phase 3Taking people
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Where
Antony, Grenoble Cedex 9, Nantes, Paris, Pringy Cedex, Rouen Cedex, Toulouse
Age
18 years and over
People
320 worldwide
Run by
Janssen - Cilag International
See details and how to join2023-505121-14-00 · EU 2023-505121-14-00
No phaseTaking people
Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis,
Where
Nice
Age
6 years to 17 years
People
40
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07529236
No phaseEnrolling by invitation
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
Where
Bordeaux
Age
18 years to 75 years
People
450
Run by
University Hospital, Bordeaux
See details and how to joinNCT03976622
No phaseTaking people
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
Where
Paris
Age
18 years and over
People
830
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06599411
No phaseTaking people
A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
Where
Amiens, Angers, Argenteuil, Arras, Bordeaux, Chalon-sur-Saône, Clermont-Ferrand, Dijon, La Tronche, Le Mans, Lens, Le Puy-en-Velay, Marcq-en-Barœul, Montpellier, Nice, Nîmes, Niort, Paris, Périgueux, Roubaix, Rouen, Saint-Germain-en-Laye, Saint-Mandé, Saint-Maur-des-Fossés, Toulon, Toulouse, Vandœuvre-lès-Nancy, Villeurbanne
Age
18 years and over
People
350 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06701513
No phaseTaking people
Deployment o the Multidisciplinary Prospective Cohort Imminent
Where
Lille
Age
18 years and over
People
2,200
Run by
University Hospital, Lille
See details and how to joinNCT04334031
No phaseTaking people
APACHE Cohort (A Psoriatic Arthritis CoHort)
Where
Créteil, Montpellier, Paris
Age
18 years to 65 years
People
425
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT03768271
No phaseTaking people
Biobank for Inflammatory Chronic Diseases and Osteoporosis
Where
Toulouse
Age
18 years to 99 years
People
2,000
Run by
University Hospital, Toulouse
See details and how to joinNCT05039216
No phaseTaking people
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
Where
Toulouse
Age
6 years to 99 years
People
800
Run by
University Hospital, Toulouse
See details and how to joinNCT06387654